Privia Health Group (NASDAQ:PRVA) Coverage Initiated by Analysts at Macquarie

Equities researchers at Macquarie began coverage on shares of Privia Health Group (NASDAQ:PRVA) in a research report issued to clients and investors on Monday,Briefing.com Automated Import reports. The brokerage set an “outperform” rating on the stock.

A number of other equities analysts have also weighed in on the company. Robert W. Baird increased their target price on Privia Health Group from $23.00 to $24.00 and gave the stock an “outperform” rating in a research note on Monday, August 26th. Barclays increased their price objective on Privia Health Group from $19.00 to $21.00 and gave the stock an “equal weight” rating in a research report on Friday, November 8th. Truist Financial boosted their target price on shares of Privia Health Group from $24.00 to $27.00 and gave the company a “buy” rating in a research report on Friday, November 8th. KeyCorp assumed coverage on shares of Privia Health Group in a research report on Friday, October 11th. They set an “overweight” rating and a $23.00 price target on the stock. Finally, JPMorgan Chase & Co. boosted their price objective on shares of Privia Health Group from $27.00 to $28.00 and gave the company an “overweight” rating in a report on Friday, November 29th. Two analysts have rated the stock with a hold rating, twelve have issued a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Buy” and an average price target of $24.79.

Privia Health Group Stock Performance

Shares of PRVA stock opened at $20.96 on Monday. The company has a market capitalization of $2.52 billion, a price-to-earnings ratio of 209.62, a PEG ratio of 5.45 and a beta of 0.83. Privia Health Group has a 52 week low of $15.92 and a 52 week high of $24.30. The company has a 50-day simple moving average of $19.96 and a 200 day simple moving average of $19.04.

Hedge Funds Weigh In On Privia Health Group

A number of institutional investors have recently modified their holdings of the business. Franklin Resources Inc. increased its position in Privia Health Group by 2.2% during the 3rd quarter. Franklin Resources Inc. now owns 1,300,240 shares of the company’s stock worth $23,092,000 after purchasing an additional 28,480 shares in the last quarter. Virtu Financial LLC acquired a new position in Privia Health Group in the 3rd quarter worth about $263,000. Neo Ivy Capital Management bought a new stake in shares of Privia Health Group during the third quarter worth about $66,000. Geode Capital Management LLC increased its stake in shares of Privia Health Group by 1.0% in the third quarter. Geode Capital Management LLC now owns 2,415,022 shares of the company’s stock valued at $43,986,000 after buying an additional 23,178 shares during the period. Finally, Barclays PLC increased its stake in shares of Privia Health Group by 240.3% in the third quarter. Barclays PLC now owns 224,018 shares of the company’s stock valued at $4,079,000 after buying an additional 158,188 shares during the period. Institutional investors and hedge funds own 94.48% of the company’s stock.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.